healthtech-logo
Submit Press Release
  • News
  • Resources
    • Newsletter
  • Insights
    • Interviews
    • Featured Articles
    • Guest Posts
  • Contact
  • News
  • Resources
    • Newsletter
  • Insights
    • Interviews
    • Featured Articles
    • Guest Posts
  • Contact
Advertise with us
Submit Press Release
If Patient Experience Is Your Priority in 2025, You Can’t Skip the Genesys Event
  • October 27, 2025
  • HealthTech Staff Writer
  • Featured

If Patient Experience Is Your Priority in 2026, You Can’t Skip the Genesys Event

Healthcare looks very different from the system we knew just a few years ago. Expectations have shifted. Patients no longer compare their healthcare experience only to other hospitals –...
Continue Reading
Dispersive Achieves HIPAA Compliance for Healthcare Security
  • October 27, 2025
  • HealthTech Staff Writer
  • HealthTech News, News, news

Dispersive Achieves HIPAA Compliance for Healthcare Security

Dispersive Holdings, Inc., a leading company in stealth networking and secure communications that work even after quantum computers are developed, announced that it has finished an independent audit to...
Continue Reading
HyHub and HyHub Duo Now Available in U.S. for HYQVIA Use
  • October 27, 2025
  • HealthTech Staff Writer
  • HealthTech News, news, News

HyHub and HyHub Duo Now Available in U.S. for HYQVIA Use

Takeda announced that the recently FDA-approved HyHub and HyHub Duo devices are now available in the U.S. for patients 17 years of age and older, as prescribed, who are...
Continue Reading
Mumtalakat and SandboxAQ Partner to Boost Bahrain Biotech
  • October 27, 2025
  • HealthTech Media Room
  • Genomics and Precision Medicine, HealthTech News, News

Mumtalakat and SandboxAQ Partner to Boost Bahrain Biotech

Bahrain Mumtalakat Holding Company BSC(c), the country’s sovereign wealth fund, has partnered with SandboxAQ, a leading global company in artificial intelligence and quantum technologies, to build a new biotech...
Continue Reading
Hemab Therapeutics Raises $157 Million to Advance Bleeding Disorder Treatments
  • October 27, 2025
  • HealthTech Staff Writer
  • HealthTech News, News, news, Technology

Hemab Therapeutics Raises $157 Million to Advance Bleeding Disorder Treatments

Hemab Therapeutics, a biotechnology company in the clinical stage that focuses on creating new preventative treatments for rare and overlooked bleeding and blood clotting disorders, has announced that they...
Continue Reading
SimBioSys Featured for AI 3D Breast Cancer Surgery Tools
  • October 27, 2025
  • Health Tech Staff Writer
  • HealthTech News, Medical Technology, news, News, Technology, Women Health

SimBioSys Featured for AI 3D Breast Cancer Surgery Tools

SimBioSys, a precision medicine company using artificial intelligence to improve cancer care, announced that its FDA-cleared TumorSight Viz technology was recently featured on ABC News Digital and Good Morning...
Continue Reading
BioDlink Completes First International Shipment of Bevacizumab to Colombia
  • October 27, 2025
  • HealthTech Staff Writer
  • HealthTech News, news, News

BioDlink Completes First International Shipment of Bevacizumab to Colombia

BioDlink has successfully shipped its first international batch of bevacizumab injection biosimilar to Colombia, working together with Kexing BioPharm. This achievement was marked by a special event with decorated...
Continue Reading
Quest AD-Detect Tests Show Accuracy In Alzheimer’s Diagnosis
  • October 27, 2025
  • HealthTech Staff Writer
  • Genomics and Precision Medicine, HealthTech News, news, News

Quest AD-Detect Tests Show Accuracy In Alzheimer’s Diagnosis

A new study published in Neurology Clinical Practice, the journal of the American Academy of Neurology, has found that two blood tests using multiple biomarkers are very accurate in...
Continue Reading
TREMFYA shows 2-year remission in Crohn’s disease
  • October 27, 2025
  • HealthTech Staff Writer
  • Genomics and Precision Medicine, HealthTech News, news, News

TREMFYA shows 2-year remission in Crohn’s disease

Johnson & Johnson has released new 96-week data from the long-term extension phases of its Phase 3 GRAVITI, GALAXI 2, and GALAXI 3 trials. The findings highlight the sustained...
Continue Reading

Posts pagination

Previous 1 2

Recent Posts

  • Health Technology Insights: Latest News And Innovations – Roundup 7 November 2025
  • Baxter Foundation Grants $2.6Million for STEM Education in Chicago
  • AI-Driven Athlete Care: Value of Physiotherapy and Counselling in Sports
  • CMS Teams with Humata Health to Streamline Clinical Approvals
  • Lumonus Raises A$25 Million in Series B to Scale AI Powered Oncology Workflows Globally

Fuel up with free Health Tech Insights

Quick Links

  • About
  • News
  • Newsletter
  • Write for Us

Insights

  • Interviews
  • Articles
  • Guest Post

Get in touch

  • Do Not Sell My Information
  • Privacy Policy
  • Contact Us

Follow Us

  • Linkedin Linkedin
Our Other Brands
Intenttech Martech Cybertech Fintech Hrtech Aitech contactcenter

Copyright © 2025  All Rights Reserved. Health Technology Insights. An Intent Amplify® Product.